Dr. Mark A. Lupo |
Fig. 01 -
Title Slide
Fig. 02 -
Disclosures
Fig. 03 -
Objectives
Fig. 04 -
Challenge
Fig. 05 -
Prevalences
Fig. 06 -
Common Causes
Fig. 07 -
Hypothyroidism
Fig. 08 -
Hyperthyroidism:GD
Fig. 09 -
When to Consider
Fig. 10 -
Common Causes 2
Fig. 11 -
Precipitating Factors
Fig. 12 -
Hashimoto's Thyroiditis
Fig. 13 -
TPO Antibodies
Fig. 14 -
Thyroglobulin Antibodies
Fig. 15 -
When to Test
Fig. 16 -
Graves' Disease Presentation
Fig. 17 -
Overt Disease
Fig. 18 -
Epidemiology
Fig. 19 -
Hypo & Hyper Graph
Fig. 20 -
TSH-R Antibody
Fig. 21 -
TSH-R Stimulatory
Fig. 22 -
Specifics
Fig. 23 -
Case 1
Fig. 24 -
Case 1 (continued)
Fig. 25 -
Case 1 (continued)
Fig. 26 -
Case 1 (continued)
Fig. 27 -
Case 1 Summary
Fig. 28 -
Case 2
Fig. 29 -
Case 2 (continued)
Fig. 30 -
Case 2 (continued)
Fig. 31 -
Case 2 Summary
Fig. 32 -
Clinical Utility Cases
Fig. 33 -
Summary
TODO, let Pete know of any updates to this content
Six (6) provocative statements concerning clinical treatment of IBD. Each statement is presented as 5 steps:Step 1: the statement & introduction, + 5 possible opinions of that statement -- please choose one
Step 2: a graph of an international survey’s opinions of that statement
Step 3: a literature review for that statement
Step 4: a graph comparing the faculty's vs an international survey’s opinions, + faculty discussion
Step 5: a brief faculty summary, plus the list of references.
Please click on any Statement or any Step tab to read this publication in the order you prefer.